Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Pregnancy Roundup Exposure Linked to Increased Risk of Low Birth Weight, Study Warns Researchers found that 99% of pregnant mothers tested had detectable levels of glyphosate in their urine due to Roundup exposure. October 28, 2022 Irvin Jackson Add Your Comments The findings of a new study link pregnancy Roundup exposure to an increased risk of giving birth to a child with low birth weight, adding to the potential health risks associated with the controversial glyphosate-based weed killer. Researchers with the Indiana University School of Medicine and the University of California San Francisco warn that prenatal exposure to the active ingredient in Roundup, glyphosate, during the first trimester increased the risk of low birth weight and Neonatal Intensive Care Unit (NICU) admission. The findings were published in the journal Environmental Health on October 11, 2022. Glyphosate is Roundup’s primary active ingredient, and this recent study is just one of the latest to raise concerns about the risks associated with exposure to the weedkiller, with glyphosate in Roundup already known to increase the risk of non-Hodgkin’s lymphoma. As a result of Monsanto’s failure to disclose that risk associated with glyphosate exposure, the company has faced tens of thousands of Roundup lawsuits, which uncovered internal documents that highlighted how the company has covered up negative findings associated with glyphosate for decades, and manipulated study results involving the widely used weed killer. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In this latest study, researchers collected random urine specimens from high risk pregnant women going through their first trimester of pregnancy between 2013 and 2016 as part of the Indiana Pregnancy Environmental Exposures Study (PEES). They looked for urine glyphosate levels and gestation-adjusted birth weight percentiles (BWT%ile) and NICU admissions. According to the findings, 99% of women tested had glyphosate (GLY) urine levels above the limit of detection. Researchers found that newborn birth weight percentiles were negatively affected related to the amount of glyphosate detected in the mother’s urine. Women with high glyphosate levels in the first trimester are 16% more likely to have a child who needed to be admitted to NICU, the data indicates. “GLY was found in 99% of pregnant women in this Midwestern cohort. Higher maternal GLY levels in the first trimester were associated with lower BWT%iles and higher NICU admission risk,” the researchers concluded. “The results warrant further investigation on the effects of GLY exposure in human pregnancies in larger population studies.” The findings came at about the same time as a study published in the November issue of Toxicology and Applied Pharmacology, which found that just before birth Roundup exposure may increase the risk of liver damage in newborns due to iron overload. Roundup Lawsuits Over Failure to Warn About Glyphosate Risks Following the release of other studies that highlighted the link between Roundup and non-Hodgkin’s lymphoma, Monsanto has faced litigation brought on behalf of individuals diagnosed with the blood cancer, each raising similar allegations that the manufacturer failed to adequately warn about the risks associated with glyphosate exposure. Following several years of litigation and massive verdicts returned in a number of early trials, Monsanto has agreed to pay billions in Roundup settlements for former users diagnosed with non-Hodgkin’s lymphoma, and the companies are expected to continue to face claims over the glyphosate-based weed killer for years to come. In response to the growing concerns and massive verdicts, the manufacturer announced plans last year to remove glyphosate from Roundup versions of the weed killers sold to U.S. residential customers by 2023. The products would still be sold under the Roundup label, but would use a different active ingredient, which has not been linked to a risk of non-Hodgkin’s lymphoma and other side effects. However, glyphosate would still be used in products sold to agricultural businesses and farmers, and in product sold in other parts of the world. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Bayer, Cancer, Glyphosate, Herbicide, Low Birth Weight, Monsanto, Non-Hodgkins Lymphoma, Pregnancy, Roundup, Weed Killer Image Credit: Photo Courtesy of <a href="https://www.flickr.com/photos/jeepersmedia/14874003257/in/photolist-oEn9Y2-oEmvHy-bTWHFx-nfCdLV-r4HEKx-rnWS2S-r6sFqE-p2qQKx-oZp21Q-p2arLx-oZoYWu-p2qRNe-oZp1K9-oWzFf8-oJWeBo-oWPq8C-p2oWDC-oJWGji-oEmb2Z-oWRdiz-GJW4pR-GGDZ27-a9RCv2-qrg4mF-rnV1kP-fwZmz-2sscR9-oe3oMa-sboouE-7Q9sz-auohod-rbkbaM-dykaWR-HadKLC-rnUQ6F-r4HT7B-rkKbUm-qr3DSm-qr3t6G-r6sNDC-qr3A3h-9Kvo44-5XtM3N-ey91rF-oe3ovi-8XXkwu-odYLgh-nWy2oy-ofPpbP-odSXiw">Mike Mozart via Flickr</a> Creative Commons More Roundup Lawsuit Stories Monsanto Roundup Settlement Avoids $2B Payout in Non-Hodgkin’s Lymphoma Lawsuit November 18, 2025 Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 Roundup Non-Hodgkin’s Lymphoma Lawsuit Remanded From MDL for Trial July 25, 2025 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: today) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025) Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 5 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 6 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: today) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025)
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 5 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 6 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)